BIOCARE NORDIC IVS: Financial statements 2020
CVR: 36454474
Source: annual report 2020, Danish Business Authority
01/04/2019 – 31/03/2020
BIOCARE NORDIC IVS (CVR 36454474) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 629 and a net result of DKK 531 compared with DKK -1,200 the year before. Equity in the 2020 report amounted to DKK -9,995.
- Gross Profit
- DKK 629
- Profit/Loss
- DKK 531
- Equity
- DKK -9,995
- Total Assets
- DKK 2,119
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | 629 | 531 | -10K | - |
| 2019 | - | -1K | -1K | -11K | - |
| 2018 | - | -877 | -877 | -9K | - |
| 2017 | - | -9K | -9K | -8K | - |
Official annual report
How creditworthy is BIOCARE NORDIC IVS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreAbout BIOCARE NORDIC IVS
BIOCARE NORDIC IVS was a Danish company of the type Iværksætterselskab based in Hvalsø, founded in 2014. The company has been dissolved on 29 October 2021. The company was registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. In 2020, the company reported a gross profit of DKK 629 and a net result of DKK 531 compared with DKK -1,200 the year before. Equity in the 2020 report amounted to DKK -9,995.
